Astrana Health, Inc. to Participate in Upcoming Investor Conference
Macquarie Initiates Astrana Health(ASTH.US) With Hold Rating, Announces Target Price $41
Astrana Health (NASDAQ:ASTH) Sheds 12% This Week, as Yearly Returns Fall More in Line With Earnings Growth
Is Astrana Health, Inc. (NASDAQ:ASTH) Potentially Undervalued?
ADUS Vs. ASTH: Which Stock Is the Better Value Option?
There May Be Underlying Issues With The Quality Of Astrana Health's (NASDAQ:ASTH) Earnings
Astrana Health Provider Groups Recognized With Highest Elite Status in America's Physician Groups 2024 Standards of Excellence Survey
BofA Securities Maintains Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $55
Astrana Health's Strategic Acquisitions and Value-Based Care Drive Bullish Buy Rating
What You Can Learn From Astrana Health, Inc.'s (NASDAQ:ASTH) P/E After Its 31% Share Price Crash
Demystifying Astrana Health: Insights From 3 Analyst Reviews
Baird Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $86
Baird Maintains Outperform on Astrana Health, Raises Price Target to $86
Astrana Health Analyst Ratings
Astrana Health Grants Equity Awards to Key Executives
Astrana Health | 10-Q: Q3 2024 Earnings Report
13 Cheap Small/mid-cap Buy-rated Stocks With Higher Beta
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating
Analyst Estimates: Here's What Brokers Think Of Astrana Health, Inc. (NASDAQ:ASTH) After Its Third-Quarter Report
Astrana Health, Inc. (ASTH) Q3 2024 Earnings Call Transcript Summary